| 1 |
The effects of lipid-regulating therapy on haemostatic parameters |
|
|
| Milionis HJ, Elisaf MS, Mikhailidis DP |
|
| CURRENT PHARMACEUTICAL DESIGN. 2003; 9 (29): 2425-2443 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
The effects of antihypertensive therapy on haemostatic parameters |
|
|
| Ganotakis ES, Papadakis JA, Vrentzos GE, et al. |
|
| CURRENT PHARMACEUTICAL DESIGN. 2003; 9 (29): 2445-2464 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Platelet function and lipid-lowering interventions |
|
|
| Milionis HJ, Elisaf MS, Mikhailidis DP |
|
| PLATELETS. 1999; 10 (6): 357-367 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Increased levels of tissue plasminogen activator antigen in essential hypertension. A population-based study in Sweden |
|
|
| Eliasson M, Jansson JH, Nilsson P, et al. |
|
| JOURNAL OF HYPERTENSION. 1997; 15 (4): 349-356 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
ADRENOCEPTORS, ENDOTHELIAL FUNCTION, AND LIPID PROFILE - EFFECTS OF ATENOLOL, DOXAZOSIN, AND CARVEDILOL |
|
|
| MAQUEDA IG |
|
| CORONARY ARTERY DISEASE. 1994; 5 (11): 909-918 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
HYPOFIBRINOLYSIS IN PATIENTS WITH HYPERTENSION AND ELEVATED CHOLESTEROL |
|
|
| JANSSON JH, JOHANSSON B, BOMAN K, et al. |
|
| JOURNAL OF INTERNAL MEDICINE. 1991; 229 (4): 309-316 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
EFFECTS OF DOXAZOSIN AND ATENOLOL ON THE FIBRINOLYTIC SYSTEM IN PATIENTS WITH HYPERTENSION AND ELEVATED SERUM-CHOLESTEROL |
|
|
| JANSSON JH, JOHANSSON B, BOMAN K, et al. |
|
| EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 1991; 40 (4): 321-326 |
|
| [Pubmed] [Google Scholar] |
|
